GET DAILY SIGNALSLifeway Foods (LWAY) Delivers Record Q3 Sales Despite Margin and EPS Pressure
Key Takeaways
- Lifeway Foods reported record quarterly net sales of $67.8 million for the third quarter of 2026, up 18.6% year over year and marking its 28th consecutive quarter of year-over-year sales growth.
- Earnings per share (EPS) came in at $0.02, below the consensus estimate of $0.06, as higher input costs weighed on profitability.
- Gross profit margin compressed to 18.0% from 28.7% a year earlier, driven by elevated costs for milk, resin-based packaging, ingredients, and transportation.
- Year-to-date net sales reached $197.7 million, up 25.8% year over year, putting the company on pace for another record annual sales total.
- Explore Major News, Today's Price Move, Price Targets, and Forecast for deeper analysis of Lifeway Foods across dedicated pages.
- Discover AI-driven trading strategies and market ideas by exploring Trending AI Robots.
Earnings Context and Why It Matters
Lifeway Foods, the leading U.S. supplier of kefir and fermented probiotic foods, reported its third-quarter 2026 results after the market close on November 12, 2026. The report matters because it tests whether the company can sustain its impressive multi-year sales momentum while defending profitability. LWAY has now delivered 28 consecutive quarters of year-over-year net sales growth, a streak spanning seven years, and was recently named to Fortune's 2026 list of the 100 Fastest-Growing Companies. Investors were watching closely to see whether surging demand for probiotic dairy products could offset rising input costs, a tension that has defined the company's recent quarters and shapes how the market values the stock. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
Lifeway Foods reported third-quarter 2026 net sales of $67.8 million, the highest quarterly sales in company history and an 18.6% increase from $57.1 million in the prior-year period. Revenue narrowly topped the consensus estimate of approximately $66.83 million. Net income fell to $0.3 million, or $0.02 per basic and diluted share, down from $3.5 million, or $0.23 per share, a year earlier.
The EPS result missed the analyst consensus of $0.06 by $0.04. The shortfall was driven by gross margin compression: gross profit margin declined to 18.0% from 28.7% a year ago, reflecting higher costs for milk, resin-based packaging, ingredients, and transportation. On a more positive note, selling, general, and administrative (SG&A) expenses improved to 16.2% of net sales from 19.6% last year, reflecting continued investment in marketing and brand awareness at a lower relative cost.
Market Reaction and Investor Sentiment
The market reaction was muted but tilted negative, reflecting a classic tension between strong top-line momentum and bottom-line disappointment. Following the release, shares slipped roughly 4% in after-hours trading, with the stock closing the regular session at $20.89. The decline suggests investors were focused on the margin compression and the EPS miss, even as record sales and the company's extended growth streak underscored durable demand for its kefir products. Sentiment heading into the print had already been cautious: the stock was down about 19% over the prior three months, and analysts had meaningfully lowered their EPS expectations from $0.27 three months earlier to $0.06 ahead of the report, indicating a market already braced for softer profitability.
Forward Outlook and Key Factors to Monitor
Looking ahead, the central question is whether LWAY can restore gross margin while preserving its sales momentum. Management has pointed to 2027 as a significant opportunity to push past prior records, but the near-term path depends heavily on the trajectory of input costs, particularly milk and packaging materials. Investors should watch for signs of whether the company can pass through price increases or realize supply-chain efficiencies that ease the margin pressure seen in the third quarter.
Another key factor is volume growth in branded drinkable kefir, which has been the primary driver of the company's record sales. Sustained consumer demand for functional and probiotic dairy products remains a tailwind, and Lifeway's category leadership positions it well to benefit. However, any supply-chain constraints, such as those flagged around its Waukesha facility, could limit the pace of future growth.
Finally, monitor expense discipline and the pace of marketing investment. SG&A as a percentage of sales improved year over year, and maintaining that leverage while funding brand awareness will be important for converting top-line growth into improved earnings. With year-to-date net sales already at roughly 93% of full-year 2025's total, the company appears well on track for another record year, but the quality of that growth, measured by margins and earnings per share, will remain the market's primary focus.
Using AI Tools in My Research
In my own process, I frequently rely on Tickeron’s AI Screener to quickly surface comparable names and spot emerging themes across the consumer staples space. It helps me cross-check fundamentals and technical signals without spending hours on manual screens, which keeps my analysis efficient when reviewing reports like this one from LWAY.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
LWAY in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 06, 2026
LWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 40 cases where LWAY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LWAY's RSI Indicator exited the oversold zone, 19 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 65 cases where LWAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for LWAY just turned positive on November 09, 2026. Looking at past instances where LWAY's MACD turned positive, the stock continued to rise in 39 of 48 cases over the following month. The odds of a continued upward trend are 81%.
Following a +3.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where LWAY advanced for three days, in 202 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Aroon Indicator entered an Uptrend today. In 147 of 210 cases where LWAY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LWAY as a result. In 71 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
LWAY moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for LWAY moved below the 200-day moving average on October 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 43 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. LWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.867) is normal, around the industry mean (6.914). LWAY has a moderately high P/E Ratio (30.069) as compared to the industry average of (7.137). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (8.458). Dividend Yield (0.015) settles around the average of (0.049) among similar stocks. P/S Ratio (1.566) is also within normal values, averaging (5.003).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of probiotic, cultured, functional dairy and non-dairy health food products
Industry FoodMajorDiversified
Advertisement